Nuwellis (NUWE) Assets Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.99% |
| Dec 31, 2025 | -21.10% |
| Sep 30, 2025 | -19.57% |
| Jun 30, 2025 | -6.89% |
| Mar 31, 2025 | -6.96% |
| Dec 31, 2024 | 11.98% |
| Sep 30, 2024 | -2.37% |
| Jun 30, 2024 | -11.54% |
| Mar 31, 2024 | -15.39% |
| Dec 31, 2023 | 2.17% |
| Sep 30, 2023 | -0.62% |
| Jun 30, 2023 | 7.29% |
| Mar 31, 2023 | 5.10% |
| Dec 31, 2022 | 5.98% |
| Sep 30, 2022 | 14.57% |
| Jun 30, 2022 | 13.26% |
| Mar 31, 2022 | 27.26% |
| Dec 31, 2021 | 32.42% |
| Sep 30, 2021 | 38.79% |
| Jun 30, 2021 | 17.93% |
| Mar 31, 2021 | 13.55% |
| Dec 31, 2020 | -3.93% |
| Sep 30, 2020 | -4.18% |
| Jun 30, 2020 | -17.75% |
| Mar 31, 2020 | -23.68% |
| Dec 31, 2019 | -29.59% |
| Sep 30, 2019 | -27.47% |
| Jun 30, 2019 | -23.41% |
| Mar 31, 2019 | -20.66% |
| Dec 31, 2018 | -30.78% |
| Sep 30, 2018 | -27.97% |
| Jun 30, 2018 | -13.54% |
| Mar 31, 2018 | 3.86% |
| Dec 31, 2017 | 4.18% |
| Sep 30, 2017 | -12.88% |
| Jun 30, 2017 | 32.35% |
| Mar 31, 2017 | 9.37% |
| Dec 31, 2016 | 0.11% |